• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成功的保守治疗:双膦酸盐药物治疗后骨质疏松患者的多发性非典型骨折:一例独特病例报告。

Successful conservative treatment: multiple atypical fractures in osteoporotic patients after bisphosphate medication: a unique case report.

作者信息

Kim Hyo-Sang, Jung Han Young, Kim Myeong-Ok, Joa Kyung-Lim, Kim Yeo Ju, Kwon Su-Yeon, Kim Chang-Hwan

机构信息

From the Department of Physical and Rehabilitation Medicine (H-SK, H-yJ, M-OK, K-LJ, S-YK, C-HK); and Department of Radiology (YJK), School of Medicine, Inha University, Incheon, Republic of Korea.

出版信息

Medicine (Baltimore). 2015 Feb;94(5):e446. doi: 10.1097/MD.0000000000000446.

DOI:10.1097/MD.0000000000000446
PMID:25654380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4602721/
Abstract

Bisphosphonates have been commonly used for the treatment of osteoporosis. However, there have been recent case reports of atypical fractures citing their long-term use, which inhibits the turnover of bone components. A 64-year-old woman visited the outpatient clinic with pain in her right thigh and ambulation difficulty. We found fractures at both pedicles of L4 vertebra. subtrochanteric region of right femur, and left femoral shaft upon a radiologic examination. She had taken intravenous ibandronic sodium for osteoporosis over 3 years. We changed the bishophonates to a parathyroid hormone because it was suspected that the multiple fractures were caused by the medication. Further, rehabilitation, including progressive weight bearing, was started. After 3 months of the conservative treatment, she was able to walk independently. In conclusion, it is necessary to evaluate the possibility of atypical fractures in osteoporotic patients when they complain of lower extremity pain and to consider alternative treatments instead of bisphosphonates.

摘要

双膦酸盐已被广泛用于治疗骨质疏松症。然而,最近有病例报告称,长期使用双膦酸盐会抑制骨成分的更新,从而导致非典型骨折。一名64岁女性因右大腿疼痛和行走困难前往门诊就诊。经放射学检查,我们发现她的L4椎体双侧椎弓根、右股骨转子下区域和左股骨干均发生骨折。她因骨质疏松症接受静脉注射伊班膦酸钠治疗已超过3年。由于怀疑多处骨折是由药物引起的,我们将双膦酸盐换成了甲状旁腺激素。此外,还开始了包括渐进性负重在内的康复治疗。经过3个月的保守治疗,她能够独立行走。总之,当骨质疏松症患者主诉下肢疼痛时,有必要评估非典型骨折的可能性,并考虑使用双膦酸盐以外的替代治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/4602721/dc445876fc67/medi-94-e446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/4602721/6f9370c12efe/medi-94-e446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/4602721/64e916cd8921/medi-94-e446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/4602721/f05fe1936cd6/medi-94-e446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/4602721/dc445876fc67/medi-94-e446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/4602721/6f9370c12efe/medi-94-e446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/4602721/64e916cd8921/medi-94-e446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/4602721/f05fe1936cd6/medi-94-e446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4382/4602721/dc445876fc67/medi-94-e446-g004.jpg

相似文献

1
Successful conservative treatment: multiple atypical fractures in osteoporotic patients after bisphosphate medication: a unique case report.成功的保守治疗:双膦酸盐药物治疗后骨质疏松患者的多发性非典型骨折:一例独特病例报告。
Medicine (Baltimore). 2015 Feb;94(5):e446. doi: 10.1097/MD.0000000000000446.
2
Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.骨质疏松症患者长期使用双膦酸盐治疗后发生的颌骨坏死(ONJ)和非典型股骨骨折(AFF)。
Osteoporos Int. 2017 Mar;28(3):1145-1147. doi: 10.1007/s00198-016-3840-z. Epub 2016 Nov 20.
3
Atypical femur fracture during bisphosphonate drug holiday: a case series.双膦酸盐药物假期期间的非典型股骨骨折:病例系列
Osteoporos Int. 2015 Jun;26(6):1755-8. doi: 10.1007/s00198-015-3063-8. Epub 2015 Apr 2.
4
Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.一名长期接受双膦酸盐治疗的女性发生双侧腓骨远端骨折。
Osteoporos Int. 2016 Feb;27(2):833-6. doi: 10.1007/s00198-015-3396-3. Epub 2015 Nov 10.
5
The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years.一名患有严重骨质疏松症且接受了超过 15 年双膦酸盐治疗的女性患者,因皮质骨应力性骨折导致自发性非典型转子下股骨干骨折,5 年随访结果。
Wien Klin Wochenschr. 2011 Nov;123(21-22):684-7. doi: 10.1007/s00508-011-0034-8. Epub 2011 Aug 15.
6
Bilateral femur fractures associated with short-term bisphosphonate use.与短期使用双膦酸盐相关的双侧股骨骨折。
Orthopedics. 2015 Feb;38(2):e139-42. doi: 10.3928/01477447-20150204-90.
7
Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.特立帕肽治疗曾接受双膦酸盐治疗的低磷酸酶血症成年患者,并由双侧非典型骨折表现。
Joint Bone Spine. 2018 May;85(3):365-367. doi: 10.1016/j.jbspin.2017.12.001. Epub 2017 Dec 12.
8
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates.接受地舒单抗或每月口服双膦酸盐治疗的绝经后骨质疏松症保加利亚女性的用药行为。
Arch Osteoporos. 2017 Dec 21;13(1):1. doi: 10.1007/s11657-017-0413-5.
9
[Treatment with bisphosphonates and atypical fractures].[双膦酸盐与非典型骨折的治疗]
Medicina (B Aires). 2009;69(6):612-8.
10
Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.在接受或未接受特立帕肽治疗的骨质疏松症患者中,与使用双膦酸盐相关的非典型转子下和股骨骨折的手术结果。
BMC Musculoskelet Disord. 2017 Dec 13;18(1):527. doi: 10.1186/s12891-017-1878-5.

引用本文的文献

1
Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathways.金雀异黄素通过调节 AKT/ERK 和 NF-κB 信号通路抑制 RANKL 诱导的破骨细胞生成,预防去卵巢诱导的骨丢失。
Int J Mol Med. 2023 May;51(5). doi: 10.3892/ijmm.2023.5246. Epub 2023 Apr 13.
2
Mapping theme trends and recognizing hot spots in postmenopausal osteoporosis research: a bibliometric analysis.绝经后骨质疏松症研究中的主题趋势映射与热点识别:一项文献计量分析
PeerJ. 2019 Nov 25;7:e8145. doi: 10.7717/peerj.8145. eCollection 2019.
3
Lateral fixation: an alternative surgical approach in the prevention of complete atypical femoral fractures.

本文引用的文献

1
Atypical bisphosphonate-associated subtrochanteric and femoral shaft stress fractures: diagnostic features on bone scan.不典型双膦酸盐相关性转子下和股骨干应力骨折:骨扫描的诊断特征。
Clin Nucl Med. 2013 May;38(5):397-9. doi: 10.1097/RLU.0b013e318286bfb6.
2
Atypical femoral fracture risk in patients treated with bisphosphonates.接受双膦酸盐治疗患者的非典型股骨骨折风险。
Arch Intern Med. 2012 Jun 25;172(12):936-7. doi: 10.1001/archinternmed.2012.1827.
3
Bisphosphonate use and atypical fractures of the femoral shaft.双膦酸盐类药物的应用与股骨干非典型骨折。
外侧固定:预防完全性非典型股骨骨折的一种替代手术方法。
Eur J Orthop Surg Traumatol. 2018 Feb;28(2):299-304. doi: 10.1007/s00590-017-2041-6. Epub 2017 Sep 18.
N Engl J Med. 2011 May 5;364(18):1728-37. doi: 10.1056/NEJMoa1010650.
4
Atypical bilateral pedicle fracture in long-term bisphosphonate therapy.长期双磷酸盐治疗中的非典型双侧椎弓根骨折。
Spine (Phila Pa 1976). 2011 Dec 15;36(26):E1769-73. doi: 10.1097/BRS.0b013e3182174d0a.
5
Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.双膦酸盐的使用与老年女性转子下或股骨干骨折的风险。
JAMA. 2011 Feb 23;305(8):783-9. doi: 10.1001/jama.2011.190.
6
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.美国临床内分泌医师协会绝经后骨质疏松症诊断与治疗临床实践医学指南。
Endocr Pract. 2010 Nov-Dec;16 Suppl 3(Suppl 3):1-37. doi: 10.4158/ep.16.s3.1.
7
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.《2010年加拿大骨质疏松症诊断与管理临床实践指南:摘要》
CMAJ. 2010 Nov 23;182(17):1864-73. doi: 10.1503/cmaj.100771. Epub 2010 Oct 12.
8
Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.与长期双膦酸盐治疗相关的股骨不足骨折。
Clin Orthop Relat Res. 2010 Dec;468(12):3384-92. doi: 10.1007/s11999-010-1535-x. Epub 2010 Aug 31.
9
Pedicle involvement on MR imaging is common in osteoporotic compression fractures.MR 成像中椎弓根受累在骨质疏松性压缩性骨折中很常见。
AJNR Am J Neuroradiol. 2010 Apr;31(4):668-73. doi: 10.3174/ajnr.A1905. Epub 2009 Dec 17.
10
Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw.
J Nucl Med. 2009 Aug;50(8):1385; author reply 1385. doi: 10.2967/jnumed.109.064568. Epub 2009 Jul 17.